Printer Friendly
The Free Library
23,403,340 articles and books


Rapida-acting insulin pen. (Products).

Novolog (insulin aspart, [rDNA origin] injection), a rapid-acting insulin analogue, is now available in the FlexPen prefilled syringe for treating diabetes. With faster absorption and onset, and a shorter duration of action, the insulin analog is suited for mealtime bolus dosing to control postprandial glycemia. The prefilled 3-mL pen can be used for 28 days without refrigeration, and provides doses in one-unit increments up to 60 units per injection (each pen contains 300 units). For more information, contact Novo Nordisk Pharmaceuticals Inc., 800-727-6500, www.novolog.com.
COPYRIGHT 2003 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Internal Medicine News
Article Type:Brief Article
Geographic Code:1USA
Date:Jul 1, 2003
Words:86
Previous Article:New antivomiting agent. (Products).
Next Article:Office flags and alerts. (Products).
Topics:



Related Articles
NOVO NORDISK INTRODUCES NOVOPEN 1.5 INSULIN DELIVERY SYSTEM; TECHNOLOGICAL ADVANCE OFFERS EASE OF USE AND ACCURACY
Devices for Taking Insulin.
Drug Update: Insulin and Insulin Analogues.
Novo Nordisk sues Sanofi-Aventis for insulin delivery device patent infringement.
Early use of insulin in the management of type 2 diabetes--the time is now.
Taking notes for diabetes care; Nypro pen monitors insulin doses.
Sanofi-aventis' SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award.
New easy-use disposable insulin pen launched.
New disposable insulin pen reduces the hassle.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters